SEC 13F Intelligence

Cutter & Co Brokerage, Inc. / REGN

Cutter & Co Brokerage, Inc.’s Regeneron Pharmaceuticals Position

Does Cutter & Co Brokerage, Inc. own Regeneron Pharmaceuticals (REGN)? Not currently — the last reported position was 10.8K shares worth $7M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$7M
Q1 2025
Shares
10.8K
% of Portfolio
+1.63%
Quarters Held
26
position exited

Position History REGN

Reported value by quarter
Q4 ’18: $2MQ4 ’18Q1 ’19: $2MQ2 ’19: $2MQ3 ’19: $2MQ4 ’19: $2MQ4 ’19Q1 ’20: $3MQ2 ’20: $4MQ3 ’20: $3MQ4 ’20: $3MQ4 ’20Q1 ’21: $3MQ2 ’21: $4MQ3 ’21: $4MQ4 ’21: $6MQ4 ’21Q1 ’22: $6MQ2 ’22: $5MQ3 ’22: $6MQ4 ’22: $6MQ4 ’22Q1 ’23: $7MQ2 ’23: $6MQ3 ’23: $7MQ4 ’23: $7MQ4 ’23Q1 ’24: $8MQ2 ’24: $8MQ3 ’24: $8MQ4 ’24: $6MQ4 ’24Q1 ’25: $7Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202510.8K$7M+1.63%
Q4 20248.0K$6M+1.38%
Q3 20247.7K$8M+1.82%
Q2 20247.8K$8M+1.98%
Q1 20247.8K$8M+1.85%
Q4 20237.9K$7M+1.92%
Q3 20238.1K$7M+1.94%
Q2 20238.1K$6M+1.72%
Q1 20238.1K$7M+2.09%
Q4 20228.2K$6M+2.00%
Q3 20228.6K$6M+2.21%
Q2 20228.9K$5M+1.79%
Q1 20228.9K$6M+1.85%
Q4 20218.9K$6M+1.54%
Q3 20217.4K$4M+1.06%
Q2 20216.5K$4M+0.83%
Q1 20216.5K$3M+0.75%
Q4 20205.6K$3M+0.71%
Q3 20205.7K$3M+0.94%
Q2 20205.7K$4M+1.16%
Q1 20205.8K$3M+1.07%
Q4 20195.6K$2M+0.74%
Q3 20195.6K$2M+0.50%
Q2 20195.5K$2M+0.54%
Q1 20195.2K$2M+0.61%
Q4 20185.2K$2M+0.74%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cutter & Co Brokerage, Inc.’s full portfolio or all institutional holders of REGN.